Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Aliment Pharmacol Ther. 2009 Oct 21;31(2):285–294. doi: 10.1111/j.1365-2036.2009.04173.x

Table 1. Patient Characteristics (n = 153)a.

Clinical variable Benign (n=96) Malignant (n=57) P valueb
Median Age, years (range) 59.5 (24-83) 68 (34-83) <0.001
 Unknown 0 0
Sex
 Male (n, %) 29 (30) 30 (53) 0.010
 Female (n, %) 67 (70) 27 (47)
 Unknown 0 0
Median BMI, kg/m2 (range) 26.4 (15.7-45.1) 24.5 (17.3-38.5) 0.263
 Unknown 43 22
Symptoms
 None (n, %) 21 (23) 17 (31) 0.247
 Abdominal pain (n, %) 63 (68) 28 (52) 0.078
 Jaundice (n, %) 5 (5) 9 (17) 0.039
 Weight Loss (n, %) 18 (19) 13 (24) 0.533
 Unknown 3 3
Family history of pancreatic cancer
 Yes (n, %) 4 (6) 7 (18) 0.105
 No (n, %) 58 (94) 33 (83)
 Unknown 34 17
Diabetes Mellitus
 Yes (n, %) 20 (21) 13 (23) 0.840
 No (n, %) 76 (79) 43 (77)
 Unknown 1 1
Smoking
 Yes (n, %) 38 (45) 22 (44) >0.99
 No (n, %) 46 (55) 28 (56)
 Unknown 12 7
Alcohol Use
 Yes (n, %) 46 (55) 26 (52) 0.858
 No (n, %) 38 (45) 24 (48)
 Unknown 12 7
History of Pancreatitis
 Yes (n, %) 33 (35) 8 (14) 0.008
 No (n, %) 62 (65) 48 (86)
 Unknown 1 1
History of Other Malignancies
 Yes (n, %) 14 (15) 17 (30) 0.036
 No (n, %) 81 (85) 39 (70)
 Unknown 1 1
Regular Aspirin Use
 Yes (n, %) 22 (24) 15 (27) 0.697
 No (n, %) 70 (76) 40 (73)
 Unknown 4 2
a

Smoking and alcohol use was defined to be positive for current or former users. History of other malignancy is defined any previous diagnosis of cancer other than pancreatic origin.

b

P-values were calculated using chi-square or Fisher exact test for categorical variables and t-test or Wilcoxon for continuous variables.